Condition · 1 treatment path
Peritoneal Carcinomatosis
Peritoneal carcinomatosis is the spread of cancer to the lining of the abdomen. It most often comes from bowel, appendix, stomach or ovarian cancer, and sometimes from mesothelioma.
Send your imaging + plan. Board-reviewed opinion in 5–10 working days.
- Treatment paths
- 1Treatment paths
- Specialties
- 2Specialties
- Typical severity
- SevereTypical severity
About peritoneal carcinomatosis
What to know
Symptoms include abdominal swelling from fluid, bloating, pain, nausea, loss of appetite and weight loss, or bowel obstruction. Diagnosis is by CT or MRI, sometimes with laparoscopy and biopsy to find the extent of disease. It is often hard to see on scans, and the spread is a key factor in outlook.
Treatment depends on the original cancer and spread. Systemic chemotherapy is standard, and fluid drainage and palliative care relieve symptoms. For carefully selected patients with limited disease, cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC) removes visible tumour and treats the remainder. It is major surgery. Treatment abroad is sought for HIPEC at high-volume centres.
Pre-flight workup
Tests to have already done
- Pathology reports for the original cancer and any peritoneal biopsy, including grade and molecular results such as MSI and RAS/BRAF status.
- CT scan of chest, abdomen and pelvis, and MRI or PET-CT if done, to show extent of disease.
- The peritoneal cancer index (PCI) score, if a surgeon or laparoscopy has calculated one.
- Treatment history: chemotherapy regimens, response, surgery notes and the dates of each.
- Blood tests including tumour markers, blood counts, kidney, liver and nutritional status, and a performance-status assessment.
Second opinion
When to get a second look
- Your team has advised palliative care only and no peritoneal surface oncology centre has reviewed your scans.
- Surgery with HIPEC is offered and the extent of disease, tumour type and your fitness have not been discussed clearly.
- The cancer is from an appendix, pseudomyxoma or mesothelioma and a specialist unit has not been consulted.
- The disease has recurred after earlier HIPEC and further options are being decided.
Talking to your doctor
Questions to ask
- What is the original cancer and how extensive is the disease in the abdomen?
- Am I a suitable candidate for cytoreductive surgery and HIPEC?
- Is complete removal of visible disease likely?
- What are the risks and the recovery time for this major operation?
- What chemotherapy comes before or after surgery?
- What outcome can I realistically expect compared with chemotherapy alone?
Outlook
Realistic prognosis
Outlook depends heavily on the type of tumour, how extensive the spread is and whether surgery can remove all visible disease. Selected patients with limited disease, for example from appendiceal or colorectal cancer, can achieve long-term control or sometimes cure after complete cytoreduction with HIPEC. Widespread disease or aggressive tumours have a poorer outlook. The operation is major with significant risks, so fitness and careful selection by an experienced centre matter.
01 · Specialties
Specialties that treat Peritoneal
Diagnostic workup
Before you pick a hospital, get the workup right
Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.
- Confirm the diagnosis on imaging or labs
For peritoneal carcinomatosis, plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
- See a oncology specialist locally first
An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
- Send us the file for a free second opinion
Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
- Pick a path with timeline + cost in writing
Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.
03 · Treatment paths
Treatment options
Where to be treated
Peritoneal Carcinomatosis treatment by destination
04 · FAQ
Common questions about peritoneal carcinomatosis
Is HIPEC suitable for everyone?
No. It is for carefully selected patients with limited disease, good general health and a tumour type where benefit is established.
What does HIPEC involve?
After surgeons remove visible tumour, warmed chemotherapy is circulated within the abdomen for a set time during the same operation.
How long is recovery?
Hospital stay is often one to two weeks or longer, with several months to regain strength.
Can the cancer come back?
Yes, recurrence is possible, so regular scans and follow-up are needed.
Clinical context
Working up peritoneal carcinomatosis properly
A condition like peritoneal carcinomatosis is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.
Diagnostic workup, in sequence
- First-line clinical assessment
History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.
- Standard imaging + labs
Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.
- Specialist diagnostic workup
Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.
- Multidisciplinary review (where indicated)
Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.
When to escalate urgently
- Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
- Loss of consciousness, severe persistent vomiting, or any focal neurological event.
- Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
- If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.
Before you book international travel
- Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
- Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
- Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
- Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
- Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Mbinu na viwango vya uhariri
This peritoneal carcinomatosis overview is written by the editorial team from published Oncology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.
- Taarifa za hospitali. Maelezo ya hospitali yanakusanywa kutoka vyanzo vya umma na tovuti za hospitali. Uidhinishaji (JCI, NABH na mengine) huonyeshwa pale tulipo na rekodi. Daima omba hospitali cheti chake cha sasa.
- Sifa za madaktari. Sifa, utaalamu na wasifu hutoka wasifu wa daktari hospitalini. Leseni hukaguliwa kwenye rejista ya baraza la kitaifa la madaktari tu pale wasifu unapoonyesha alama ya "Leseni imehakikiwa" yenye tarehe.
- Bei. Viwango vya bei ni vya kukadiria, vimekusanywa kutoka orodha za bei na vifurushi vya hospitali na huonyeshwa na tarehe ya mwisho ya kusasishwa. Unacholipa ni kile kilichoandikwa kwenye nukuu ya hospitali.
- Maandishi ya kitabibu. Imeandikwa na timu ya wahariri ya Medcasts kutoka vyanzo vya kliniki vilivyochapishwa. Isipokuwa ukurasa umetaja mhakiki kwa jina, haujakaguliwa na daktari.
- Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.
Peritoneal Carcinomatosis
Continue evaluating peritoneal carcinomatosis care
Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating peritoneal carcinomatosis.
- Surgeons Doctors treating Peritoneal Carcinomatosis Volume-ranked specialists across all relevant specialties.
- Specialty Oncology hub Programs, surgeons, hospitals across oncology.
- Specialty GI Surgery Alternative specialty involved in care for this condition.
- Procedure Cytoreductive Surgery + HIPEC First-line treatment with success rates, recovery, hospital pricing.
- Browse All 79 conditions Map condition → specialty → first-line treatment.
- Browse 9 destination countries Cost-of-care profiles, hospital programs, visa playbooks.
- Compare Hospital comparison Side-by-side accreditations, ratings, beds, and pricing.
- Compare Doctor comparison Surgeons compared on volume, fees, languages, video-consult availability.
- Tool Match-me triage Three questions, get a specialty + destination + 3-hospital shortlist.
- Tool Cost calculator Hospital-reported pricing across procedures × destinations.
- Action Free second opinion Independent panel review of your case in 48 hours — no charge.
Hatua inayofuata · Peritoneal Carcinomatosis
Free second opinion on your Peritoneal case.
Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.